Showing results (1-10 of 610) with videos related to
Sort By:
Pageof 61
Current Opinion in Investigational Drugs (London, England : 2000)|December 15, 2010
Necitumumab, a fully human IgG1 mAb directed against the EGFR for the potential treatment of cancerRodrigo Dienstmann, Josep TaberneroAnti-Cancer Agents in Medicinal Chemistry|March 24, 2011
BRAF as a target for cancer therapyRodrigo Dienstmann, Josep TaberneroCancer Journal (Sudbury, Mass.)|June 25, 2016
Spectrum of Gene Mutations in Colorectal Cancer: Implications for TreatmentRodrigo Dienstmann, Josep TaberneroAmerican Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|September 21, 2018
Molecular Subtypes and the Evolution of Treatment Decisions in Metastatic Colorectal CancerRodrigo Dienstmann, Ramon Salazar, Josep TaberneroCurrent Opinion in Oncology|March 16, 2013
Biomarker-driven patient selection for early clinical trialsRodrigo Dienstmann, Jordi Rodon, Josep TaberneroAmerican Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 27, 2014
The evolution of our molecular understanding of colorectal cancer: what we are doing now, what the future holds, and how tumor profiling is just the beginningRodrigo Dienstmann, Ramon Salazar, Josep TaberneroCurrent Clinical Pharmacology|March 22, 2012
Application of monoclonal antibodies as cancer therapy in solid tumorsRodrigo Dienstmann, Ben Markman, Josep TaberneroAmerican Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|January 24, 2014
Drug development in the era of personalized oncology: from population-based trials to enrichment and prescreening strategiesRodrigo Dienstmann, Jordi Rodon, Josep TaberneroCancer Journal (Sudbury, Mass.)|March 24, 2011
Molecular predictors of response to chemotherapy in colorectal cancerRodrigo Dienstmann, Eduardo Vilar, Josep TaberneroJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 2015
Personalizing colon cancer adjuvant therapy: selecting optimal treatments for individual patientsRodrigo Dienstmann, Ramon Salazar, Josep TaberneroPageof 61